Solving Rare Disease Biopharma’s Biggest Challenges with Patient-Centric Innovation
Who we are
SWII.CH Health is a digital-first consultancy specializing in rare disease insights and engagement. We partner with biopharma companies to overcome the unique challenges of the rare disease landscape—from identifying elusive patient populations to driving disease awareness and fostering meaningful, long-term advocacy.
PATIENT ENGAGEMENT EXPERTS
BEHAVIOURAL RESEARCHERS
OMNICHANNEL COMMUNICATIONS SPECIALISTS
Our approach combines cutting-edge digital tools, behavioral science, and real-world insights with a flexible virtual model of experts. This model allows us to quickly scale and deliver tailored solutions by bringing together top-tier talent and a global network of rare disease patient partners. These partners, with their lived experiences and professional insights, ensure that every strategy is authentic, impactful, and aligned with the needs of the rare disease community.
Rare Disease Expertise: Decades of experience navigating the complexities of rare diseases and biopharma innovation.
Digital-First, Scalable Solutions: Leveraging AI, advanced analytics, and omnichannel strategies to solve real-world challenges.
Community-Driven Approach: Collaborating with patient advocates, caregivers, and HCPs through our extensive network to create authentic, patient-centered solutions.
Virtual Model of Excellence: Access to a dynamic pool of experts and patient partners to deliver fast, flexible, and impactful results.
How we work
BEHAVIORAL SCIENCE
We focus on the science behind behavior change and infuse our work with insights mined using validated behavioral science techniques.
PATIENT ENGAGEMENT
Our engagement strategy process utilises behavioral change models to inform intervention. In this system, capability, opportunity, and motivation are all leverage points for stakeholder engagement.
DIGITAL SOLUTIONS
A digital first company, we know that optimal patient engagement often sits hand in hand with the right digital solutions and we use insights based processes to select the right tools for our clients and their stakeholders in orphan disease.
Our leadership team
Rob Wyer
Rob has over 15 years experience working in digital communications. He founded the independent digital agency Elevator Digital which was acquired by Publicis Groupe. Rob has since held senior roles with Saatchi & Saatchi Health and Razorfish.
Rachel Jones
Rachel is a Pharmacist and behavioural scientist by background and has had a 15 year long career in a large Pharma company in Medical Affairs, Digital Innovation and Patient Affairs. She has worked as a Management Consultant across Europe and the US in areas of patient centricity and digital delivery.
